Takeda clears key hurdle as investors back $59 billion Shire deal
2018-12-5 05:48 pm
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Read The Rest at
Russia's Gazprom Neft sticking with plan to...
Unilever's Polman calls for trust in farewell...
You May Also Like
Look Back at Julie Andrews and Rex Harrison in...
Dumbo: Disney’s endearing little elephant is back
Happy that Chess is back in Asian Games:...
OneWeb raises fresh $1.25 billion for internet...
Gautam Gambhir says Indians should back team if...
Rio de Janeiro government takes back control of...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version